Home
Chimeric Therapeutics Ltd
ADVENT-AML Phase 1B clinical trial open to enrolment
Business
Jan 15 2024
5 min read

ADVENT-AML Phase 1B clinical trial open to enrolment

news images

Chimeric Therapeutics Ltd has released a press release.

View Attachment